185 related articles for article (PubMed ID: 9173898)
1. Prothrombinase is protected from inactivation by tissue factor pathway inhibitor: competition between prothrombin and inhibitor.
Franssen J; Salemink I; Willems GM; Wun TC; Hemker HC; Lindhout T
Biochem J; 1997 Apr; 323 ( Pt 1)(Pt 1):33-7. PubMed ID: 9173898
[TBL] [Abstract][Full Text] [Related]
2. Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase.
Mast AE; Broze GJ
Blood; 1996 Mar; 87(5):1845-50. PubMed ID: 8634431
[TBL] [Abstract][Full Text] [Related]
3. Contribution of regions distal to glycine-160 to the anticoagulant activity of tissue factor pathway inhibitor.
Lockett JM; Mast AE
Biochemistry; 2002 Apr; 41(15):4989-97. PubMed ID: 11939795
[TBL] [Abstract][Full Text] [Related]
4. Probable regulation of factor VIIa-tissue factor and prothrombinase by factor Xa-TFPI and TFPI in vivo.
Gouin-Thibault I; Dewar L; Craven S; Kulczycky M; Wun TC; Ofosu FA
Br J Haematol; 1996 Dec; 95(4):738-46. PubMed ID: 8982054
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of the inhibition of human factor Xa by full-length and truncated recombinant tissue factor pathway inhibitor.
Lindhout T; Willems G; Blezer R; Hemker HC
Biochem J; 1994 Jan; 297 ( Pt 1)(Pt 1):131-6. PubMed ID: 8280090
[TBL] [Abstract][Full Text] [Related]
6. Role of exosite binding modulators in the inhibition of Fxa by TFPI.
Peraramelli S; Thomassen S; Heinzmann A; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M; Rosing J
Thromb Haemost; 2016 Mar; 115(3):580-90. PubMed ID: 26607136
[TBL] [Abstract][Full Text] [Related]
7. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II.
van 't Veer C; Mann KG
J Biol Chem; 1997 Feb; 272(7):4367-77. PubMed ID: 9020158
[TBL] [Abstract][Full Text] [Related]
8. The effect of heparin on the regulation of factor VIIa-tissue factor activity by tissue factor pathway inhibitor.
Hamamoto T; Kisiel W
Blood Coagul Fibrinolysis; 1996 Jun; 7(4):470-6. PubMed ID: 8840000
[TBL] [Abstract][Full Text] [Related]
9. Tissue factor pathway inhibitor: regulation of its inhibitory activity by phospholipid surfaces.
Lindhout T; Salemink I; Valentin S; Willems GM
Haemostasis; 1996 Oct; 26 Suppl 4():89-97. PubMed ID: 8979115
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of the inhibition of factor Xa and the tissue factor-factor VIIa complex by the tissue factor pathway inhibitor in the presence and absence of heparin.
Jesty J; Wun TC; Lorenz A
Biochemistry; 1994 Oct; 33(42):12686-94. PubMed ID: 7918495
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of prothrombinase at macroscopic lipid membranes: competition between antithrombin and prothrombin.
Billy D; Speijer H; Lindhout T; Hemker HC; Willems GM
Biochemistry; 1995 Oct; 34(41):13699-704. PubMed ID: 7577961
[TBL] [Abstract][Full Text] [Related]
12. An inhibitory monoclonal antibody to factor X that blocks prothrombin activation but not prothrombinase enzyme assembly.
Church WR; Messier TL; Tucker MM; Mann KG
Blood; 1988 Dec; 72(6):1911-21. PubMed ID: 2461754
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces.
Hamamoto T; Yamamoto M; Nordfang O; Petersen JG; Foster DC; Kisiel W
J Biol Chem; 1993 Apr; 268(12):8704-10. PubMed ID: 8473315
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tissue factor-factor VIIa-catalyzed factor X activation by factor Xa-tissue factor pathway inhibitor. A rotating disc study on the effect of phospholipid membrane composition.
Salemink I; Franssen J; Willems GM; Hemker HC; Lindhout T
J Biol Chem; 1999 Oct; 274(40):28225-32. PubMed ID: 10497177
[TBL] [Abstract][Full Text] [Related]
15. Assembly of the prothrombinase complex enhances the inhibition of bovine factor Xa by tick anticoagulant peptide.
Krishnaswamy S; Vlasuk GP; Bergum PW
Biochemistry; 1994 Jun; 33(25):7897-907. PubMed ID: 8011652
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa.
Wesselschmidt R; Likert K; Girard T; Wun TC; Broze GJ
Blood; 1992 Apr; 79(8):2004-10. PubMed ID: 1562726
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of factor Xa in the prothrombinase complex by the carboxyl-terminal domain of antistasin.
Mao SS; Przysiecki CT; Krueger JA; Cooper CM; Lewis SD; Joyce J; Lellis C; Garsky VM; Sardana M; Shafer JA
J Biol Chem; 1998 Nov; 273(46):30086-91. PubMed ID: 9804761
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of LDL-associated tissue factor pathway inhibitor.
Augustsson C; Hilden I; Petersen LC
Thromb Res; 2014 Jul; 134(1):132-7. PubMed ID: 24787991
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of the prothrombinase complex: factor Va alters macromolecular recognition of a tick anticoagulant peptide mutant by factor Xa.
Betz A; Vlasuk GP; Bergum PW; Krishnaswamy S
Biochemistry; 1997 Jan; 36(1):181-91. PubMed ID: 8993332
[TBL] [Abstract][Full Text] [Related]
20. Prothrombin kringle 1 domain interacts with factor Va during the assembly of prothrombinase complex.
Deguchi H; Takeya H; Gabazza EC; Nishioka J; Suzuki K
Biochem J; 1997 Feb; 321 ( Pt 3)(Pt 3):729-35. PubMed ID: 9032460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
